• Journal of Chest Surgery
• /
• 제5권2호
• /
• pp.107-112
• /
• 1972

Recently we experienced a case of the portal hypertension, extrahepatlc origin in the National Medical Center, Seoul. The case was a male aged 19 who was undergone the elective splenorenal shunt with splenectomy 9 years ago and emergency ligation of the coronary vein because of recurred variceal rupture 6 years later and had recurring esophageal varices with bleeding this time.At the age of 10 he had been occasionally suffering from nasal bleeding and visited to our Pediatric department, when there was encountered for the first time the splenomegaly, esophageal varices in the lower third esophagus on the esophagogram, and stenosis and kinking of the portal vein with rich collateral circulation on the splenoportography without hepatic functional impairment.The elective splenorenal shunt with splenectomy was undergone under the diagnosis of portal hypertension due to congenital anomaly of the portal vein and postoperatlvely no troubles had been obtained until postoperative 1st attack of massive hematemesis due to esophagenl variceal rupture recurred about 6 years later which was confirmed by control esophagogram and it was resulted by stenosis of previous anastomotic site of the splenorenal shunt.Then emergency ligation of the coronary vein was only made for bleeding control and no episodes of hematemesis had been encountered thereafter until April 1972 about 3 years after the 2nd operation, when hematemesis recurred again. In this time, recurring esophageal varices were noted in the lower third esophagus on the control esophagogram and he was employed side to end mesocaval shunt as the final step of portal decompression,and following results were obtained. 1] No postoperatlve troubles as leg edema or pain: Postoperatively leg elevation and elastic bandage on the both legs were employed until discharge. 2] During operation the portal pressure was 300 mm $H_2O$ and immediately lowered to 170 mm $H_2O$ after shunt.

• Korean Journal of Radiology
• /
• 제23권1호
• /
• pp.68-76
• /
• 2022

Objective: Percutaneous portal vein (PV) stent placement can be an effective treatment for symptoms associated with portal hypertension. This study aimed to evaluate the effect of PV stenting on the overall survival (OS) in patients with malignant PV stenosis. Materials and Methods: Two groups of patients with malignant PV stenosis were compared in this retrospective study involving two institutions. A total of 197 patients who underwent PV stenting between November 2016 and August 2019 were established as the stent group, whereas 29 patients with PV stenosis who were treated conservatively between July 2013 and October 2016 constituted the no-stent group. OS was compared between the two groups before and after propensity score matching (PSM). Risk factors associated with OS were evaluated using the Cox proportional hazards model. Procedure-associated adverse events were also evaluated. Results: The stent group finally included 100 patients (median age, 65 [interquartile range, 58-71] years; 64 male). The no-stent group included 22 patients (69 [61-75] years, 13 male). Stent placement was successful in 95% of attempted cases, and the 1- and 2-year stent occlusion-free survival rate was 56% (95% confidence interval, 45%-69%) and 44% (32%-60%), respectively. The median stent occlusion-free survival time was 176 (interquartile range, 70-440) days. OS was significantly longer in the stent group than in the no-stent group (median 294 vs. 87 days, p < 0.001 before PSM, p = 0.011 after PSM). The 1- and 3-year OS rates before PSM were 40% and 11%, respectively, in the stent group. The 1-year OS rate after PSM was 32% and 5% in the stent and no-stent groups, respectively. Anemia requiring transfusion (n = 2) and acute thrombosis necessitating re-stenting (n = 1) occurred in three patients in the stent group within 1 week. Conclusion: Percutaneous placement of a PV stent may be effective in improving OS in patients with malignant PV stenosis.

• Journal of Chest Surgery
• /
• 제27권8호
• /
• pp.710-713
• /
• 1994

The Budd-Chiari syndrome is a rare type of portal hypertension caused by complete or incomplete obstruction of the hepatic vein or the corresponding portion of the inferior vena cava or both. In this case, the obstruction was located just beneath the diaphragm, above the right hepatic vein opening, which was confirmed by vena cavography preoperatively. Budd-Chiari syndrome with stenosis or thrombosis of the inferior vena cava may be cured by prosthetic bypass to the right atrium. This case is caused by thrombus of unknowed primary origin. Combined mesoatrial and cavoatrial shunt should be encouraged in this specific situation. Postoperatively, there were marked fall of venous pressure and symptoms and signs improved remarkably.

• Journal of Chest Surgery
• /
• 제18권4호
• /
• pp.673-678
• /
• 1985

A 21 year-old male patient had a diagnosis of Budd-Chiari syndrome caused by inferior vena caval obstruction. Conservative medical therapy failed to control the symptoms of both portal hypertension and inferior vena caval stasis. Portocaval or mesocaval shunts may relive the symptoms of chronic forms of Budd-Chiari syndrome. But when inferior vena caval stenosis is severe, another procedure has to be used. Cavoatrial or portoatrial shunt has been suggested. Therefore, a long Dacron graft was placed from the inferior vena cava just below the left renal vein to the right atrium. He exhibited almost complete relief of symptoms for 1.5 year postoperatively. And there was angiographic proof of patency of the graft. This simple procedure should be encouraged in treatment of these patients.

• 대한약리학회지
• /
• 제24권1호
• /
• pp.63-70
• /
• 1988

문맥 고혈압 동물에서 내장장기의 혈류역동학적 변동으로서 문맥압의 증가와 동반하여 장간의 혈류량 증가와 혈관저항의 감소뿐만 아니라 전신 혈관저항의 감소가 특징적으로 야기된다. 문맥고혈압에 있어서 propranolol이 beta 1과 beta 2 수용체의 봉쇄작용으로 문맥고혈압을 저하시킨다는 점에서 사용되기도 한다. 본 실험에서는 흰쥐에서 문맥을 부분적으로 결찰하여 문맥고혈압을 야기하고 10일 후에 내장장기의 혈류역동학적 변동과 혈관 수축성 약물에 대한 반응성의 변동을 관찰하였다. 동시에 이에 대한 propranolol의 효과도 검토하였다. 문맥 결찰 후에는 비 펄프압의 증가와 동반하여 내장장기의 혈류량과 모세혈관압 증가가 야기되었고 동시에 모세혈관 전 저항(Ra)과 모세혈관 후 저항(Rv)은 저하되었다. Noradrenaline에 대한 Rv의 증가반응, adrenaline에 대한 Ra와 Rv의 증가반응, 및 phenylephrine에 대한 상장간막 동맥압, Ra및 Rv의 증가반응이 특징적으로 문맥결찰군에서 대조군에 비하여 현저히 약화되었다. Propranolol 처치군(PPL-3)에서 장간막 혈류량의 감소가 초래되었고, 문맥결찰군에서 저하된 Ra와 Rv가 propranolol투여로 대조군 수치로 회복되 었다. 이러한 성적의 결과로 문맥 결찰에 의하여 장간막 혈류량 증가와 동반된 Ra와 Rv의 저하는 비 펄프압 증가로 야기된 것으로 추측되며 내장장기 혈류역동학적 및 혈관 반응도의 변동은 장기적인 propranolol 처치로 효과있게 교정되는 점으로 미루어 내장장기의 과혈류역동은 내장장기 혈관의 아드레나린성 수용체의 기능변동과 밀접한 관련이 있다고 사료되었다.